Review



pshp1 antibody  (STEMCELL Technologies Inc)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    STEMCELL Technologies Inc pshp1 antibody
    Western blotting analysis (A) demonstrated significant increase in the level of <t>pVEGF-R2</t> after 5 and 60 minutes from the beginning of treatment with 12-HETE. *P<0.05 vs Control (C) and other time points. There was simultaneous decrease in the level of pSHP1. Immunofluorescence of pSHP1 (green) in REC also showed marked decrease in the pSHP1 immunoreactivity by 12-HETE compared to the control. * P<0.05 vs control (n = 3).
    Pshp1 Antibody, supplied by STEMCELL Technologies Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/pshp1 antibody/product/STEMCELL Technologies Inc
    Average 90 stars, based on 1 article reviews
    pshp1 antibody - by Bioz Stars, 2026-05
    90/100 stars

    Images

    1) Product Images from "12/15-Lipoxygenase-Derived Lipid Metabolites Induce Retinal Endothelial Cell Barrier Dysfunction: Contribution of NADPH Oxidase"

    Article Title: 12/15-Lipoxygenase-Derived Lipid Metabolites Induce Retinal Endothelial Cell Barrier Dysfunction: Contribution of NADPH Oxidase

    Journal: PLoS ONE

    doi: 10.1371/journal.pone.0057254

    Western blotting analysis (A) demonstrated significant increase in the level of pVEGF-R2 after 5 and 60 minutes from the beginning of treatment with 12-HETE. *P<0.05 vs Control (C) and other time points. There was simultaneous decrease in the level of pSHP1. Immunofluorescence of pSHP1 (green) in REC also showed marked decrease in the pSHP1 immunoreactivity by 12-HETE compared to the control. * P<0.05 vs control (n = 3).
    Figure Legend Snippet: Western blotting analysis (A) demonstrated significant increase in the level of pVEGF-R2 after 5 and 60 minutes from the beginning of treatment with 12-HETE. *P<0.05 vs Control (C) and other time points. There was simultaneous decrease in the level of pSHP1. Immunofluorescence of pSHP1 (green) in REC also showed marked decrease in the pSHP1 immunoreactivity by 12-HETE compared to the control. * P<0.05 vs control (n = 3).

    Techniques Used: Western Blot, Control, Immunofluorescence

    There was marked increase in the pVEGF immunoreactivity in retinal sections from diabetic mice in comparison to the control. This was prevented by baicalein treatment (A). Note that pVEGF-R2 expression was localized mainly in Muller cells in the control (long arrows), however the reaction was also increased in retinal vessels during diabetes (short arrows) * P<0.05 vs control and # P<0.05 vs baicalein treated group (n = 5). pSHP immunolocalization (B) revealed marked decrease in diabetes which was restored by baicalein treatment. Note that pSHP is expressed in different retinal layers and also in relation to retinal vessels (arrows) in normal retina. In diabetes the decrease in pSHP occurred mainly in inner retina including retinal vessels. * P<0.05 vs control and # P<0.05 vs baicalein treated group (n = 5).
    Figure Legend Snippet: There was marked increase in the pVEGF immunoreactivity in retinal sections from diabetic mice in comparison to the control. This was prevented by baicalein treatment (A). Note that pVEGF-R2 expression was localized mainly in Muller cells in the control (long arrows), however the reaction was also increased in retinal vessels during diabetes (short arrows) * P<0.05 vs control and # P<0.05 vs baicalein treated group (n = 5). pSHP immunolocalization (B) revealed marked decrease in diabetes which was restored by baicalein treatment. Note that pSHP is expressed in different retinal layers and also in relation to retinal vessels (arrows) in normal retina. In diabetes the decrease in pSHP occurred mainly in inner retina including retinal vessels. * P<0.05 vs control and # P<0.05 vs baicalein treated group (n = 5).

    Techniques Used: Comparison, Control, Expressing



    Similar Products

    pshp1 y564 monoclonal antibody  (Cell Signaling Technology Inc)
    94
    Cell Signaling Technology Inc pshp1 y564 monoclonal antibody
    Pshp1 Y564 Monoclonal Antibody, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/pshp1 y564 monoclonal antibody/product/Cell Signaling Technology Inc
    Average 94 stars, based on 1 article reviews
    pshp1 y564 monoclonal antibody - by Bioz Stars, 2026-05
    94/100 stars
    		  Buy from Supplier
    rabbit monoclonal antibody against shp1 phosphorylation pshp1  (Cell Signaling Technology Inc)
    95
    Cell Signaling Technology Inc rabbit monoclonal antibody against shp1 phosphorylation pshp1
    Rabbit Monoclonal Antibody Against Shp1 Phosphorylation Pshp1, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit monoclonal antibody against shp1 phosphorylation pshp1/product/Cell Signaling Technology Inc
    Average 95 stars, based on 1 article reviews
    rabbit monoclonal antibody against shp1 phosphorylation pshp1 - by Bioz Stars, 2026-05
    95/100 stars
    		  Buy from Supplier
    pshp1 antibody  (ECM Biosciences)
    90
    ECM Biosciences pshp1 antibody
    Pshp1 Antibody, supplied by ECM Biosciences, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/pshp1 antibody/product/ECM Biosciences
    Average 90 stars, based on 1 article reviews
    pshp1 antibody - by Bioz Stars, 2026-05
    90/100 stars
    		  Buy from Supplier
    pshp1 antibody  (STEMCELL Technologies Inc)
    90
    STEMCELL Technologies Inc pshp1 antibody
    Western blotting analysis (A) demonstrated significant increase in the level of <t>pVEGF-R2</t> after 5 and 60 minutes from the beginning of treatment with 12-HETE. *P<0.05 vs Control (C) and other time points. There was simultaneous decrease in the level of pSHP1. Immunofluorescence of pSHP1 (green) in REC also showed marked decrease in the pSHP1 immunoreactivity by 12-HETE compared to the control. * P<0.05 vs control (n = 3).
    Pshp1 Antibody, supplied by STEMCELL Technologies Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/pshp1 antibody/product/STEMCELL Technologies Inc
    Average 90 stars, based on 1 article reviews
    pshp1 antibody - by Bioz Stars, 2026-05
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    Western blotting analysis (A) demonstrated significant increase in the level of pVEGF-R2 after 5 and 60 minutes from the beginning of treatment with 12-HETE. *P<0.05 vs Control (C) and other time points. There was simultaneous decrease in the level of pSHP1. Immunofluorescence of pSHP1 (green) in REC also showed marked decrease in the pSHP1 immunoreactivity by 12-HETE compared to the control. * P<0.05 vs control (n = 3).

    Journal: PLoS ONE

    Article Title: 12/15-Lipoxygenase-Derived Lipid Metabolites Induce Retinal Endothelial Cell Barrier Dysfunction: Contribution of NADPH Oxidase

    doi: 10.1371/journal.pone.0057254

    Figure Lengend Snippet: Western blotting analysis (A) demonstrated significant increase in the level of pVEGF-R2 after 5 and 60 minutes from the beginning of treatment with 12-HETE. *P<0.05 vs Control (C) and other time points. There was simultaneous decrease in the level of pSHP1. Immunofluorescence of pSHP1 (green) in REC also showed marked decrease in the pSHP1 immunoreactivity by 12-HETE compared to the control. * P<0.05 vs control (n = 3).

    Article Snippet: Retina homogenates were reacted with primary antibodies against NOX2 or gp91 phox (mouse monoclonal, 1 500, BD transduction laboratories, San Diego, CA), ZO-1, 2 μg/ml (Invitrogen, Eugene, OR), ICAM-1 (1 250, Santa Cruz, Santa Cruz, CA), pVEGF-R2, VEGF-R2 (1 250, Abcam, Cambridge, MA) and pSHP1 (1 200, Stem Cell Technologies, Vancouver, Canada).

    Techniques: Western Blot, Control, Immunofluorescence

    There was marked increase in the pVEGF immunoreactivity in retinal sections from diabetic mice in comparison to the control. This was prevented by baicalein treatment (A). Note that pVEGF-R2 expression was localized mainly in Muller cells in the control (long arrows), however the reaction was also increased in retinal vessels during diabetes (short arrows) * P<0.05 vs control and # P<0.05 vs baicalein treated group (n = 5). pSHP immunolocalization (B) revealed marked decrease in diabetes which was restored by baicalein treatment. Note that pSHP is expressed in different retinal layers and also in relation to retinal vessels (arrows) in normal retina. In diabetes the decrease in pSHP occurred mainly in inner retina including retinal vessels. * P<0.05 vs control and # P<0.05 vs baicalein treated group (n = 5).

    Journal: PLoS ONE

    Article Title: 12/15-Lipoxygenase-Derived Lipid Metabolites Induce Retinal Endothelial Cell Barrier Dysfunction: Contribution of NADPH Oxidase

    doi: 10.1371/journal.pone.0057254

    Figure Lengend Snippet: There was marked increase in the pVEGF immunoreactivity in retinal sections from diabetic mice in comparison to the control. This was prevented by baicalein treatment (A). Note that pVEGF-R2 expression was localized mainly in Muller cells in the control (long arrows), however the reaction was also increased in retinal vessels during diabetes (short arrows) * P<0.05 vs control and # P<0.05 vs baicalein treated group (n = 5). pSHP immunolocalization (B) revealed marked decrease in diabetes which was restored by baicalein treatment. Note that pSHP is expressed in different retinal layers and also in relation to retinal vessels (arrows) in normal retina. In diabetes the decrease in pSHP occurred mainly in inner retina including retinal vessels. * P<0.05 vs control and # P<0.05 vs baicalein treated group (n = 5).

    Article Snippet: Retina homogenates were reacted with primary antibodies against NOX2 or gp91 phox (mouse monoclonal, 1 500, BD transduction laboratories, San Diego, CA), ZO-1, 2 μg/ml (Invitrogen, Eugene, OR), ICAM-1 (1 250, Santa Cruz, Santa Cruz, CA), pVEGF-R2, VEGF-R2 (1 250, Abcam, Cambridge, MA) and pSHP1 (1 200, Stem Cell Technologies, Vancouver, Canada).

    Techniques: Comparison, Control, Expressing